110 related articles for article (PubMed ID: 2513282)
1. Serine and D-serine position-1 substituted angiotensin II analogues. Synthesis using new 2,3,5,6-tetrafluorophenyl active esters and biological activities.
Hui KY; Holleran EM; Kovacs J
Int J Pept Protein Res; 1989 Sep; 34(3):177-83. PubMed ID: 2513282
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships for the carboxy-terminus truncated analogues of angiotension II, a new class of angiotensin II antagonists.
Bovy PR; O'Neal JM; Olins GM; Patton DR; McMahon EG; Palomo M; Koepke JP; Salles KS; Trapani AJ; Smits GJ
J Med Chem; 1990 May; 33(5):1477-82. PubMed ID: 2329570
[TBL] [Abstract][Full Text] [Related]
3. Topographic probes of angiotensin and receptor: potent angiotensin II agonist containing diphenylalanine and long-acting antagonists containing biphenylalanine and 2-indan amino acid in position 8.
Hsieh KH; LaHann TR; Speth RC
J Med Chem; 1989 Apr; 32(4):898-903. PubMed ID: 2704034
[TBL] [Abstract][Full Text] [Related]
4. Effects of D-amino acid substitution on antagonist activities of angiotensin II analogues.
Samanen J; Narindray D; Adams W; Cash T; Yellin T; Regoli D
J Med Chem; 1988 Mar; 31(3):510-6. PubMed ID: 3346871
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activities of [beta-Malyl1]- and [beta-Malyl1, Leu8]-angiotensin II analogues.
Cordopatis P; Matsoukas J; Michel A; Janen J; Theodoropoulos D
Experientia; 1983 Apr; 39(4):353-5. PubMed ID: 6832307
[TBL] [Abstract][Full Text] [Related]
6. The importance of residues 2 (arginine) and 6 (histidine) in high-affinity angiotensin II antagonists.
Samanen J; Brandeis E; Narindray D; Adams W; Cash T; Yellin T; Regoli D
J Med Chem; 1988 Apr; 31(4):737-41. PubMed ID: 3351849
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of angiotensin II antagonists containing N- and O-methylated and other amino acid residues.
Khosla MC; Mũnoz-Ramírez H; Hall MM; Smeby RR; Khairallah PA; Bumpus FM; Peach MJ
J Med Chem; 1976 Feb; 19(2):244-50. PubMed ID: 2777
[TBL] [Abstract][Full Text] [Related]
8. Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazoles.
Kubo K; Inada Y; Kohara Y; Sugiura Y; Ojima M; Itoh K; Furukawa Y; Nishikawa K; Naka T
J Med Chem; 1993 Jun; 36(12):1772-84. PubMed ID: 8510105
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of angiotensin II antagonists with variations in position 5.
Nyéki O; Szalay KS; Kisfaludy L; Kárpáti E; Szporny L; Makara GB; Varga B
J Med Chem; 1987 Oct; 30(10):1719-24. PubMed ID: 3656348
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
[TBL] [Abstract][Full Text] [Related]
11. Receptor binding interactions of the angiotensin II antagonist, 125I-[sarcosine1,leucine8]angiotensin II, with mammalian brain and peripheral tissues.
Bennett JP; Snyder SH
Eur J Pharmacol; 1980 Oct; 67(1):11-25. PubMed ID: 6252019
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activities of analogues of angiotensins II and III containing O-methyltyrosine and D-tryptophan.
Matsoukas JM; Goghari MH; Scanlon MN; Franklin KJ; Moore GJ
J Med Chem; 1985 Jun; 28(6):780-3. PubMed ID: 4009600
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin analogues palmitoylated in positions 1 and 4.
Maletínská L; Neugebauer W; Pérodin J; Lefebvre M; Escher E
J Med Chem; 1997 Sep; 40(20):3271-9. PubMed ID: 9379447
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of [1-sarcosine, 8-O-methylserine]angiotensin II and 1-substituted analogues of [8-threonine]angiotensin II as antagonists of angiotensin II.
Khosla MC; Hall MM; Munoz-Ramírez H; Khairallah PA; Bumpus FM
J Med Chem; 1977 Feb; 20(2):253-6. PubMed ID: 836496
[TBL] [Abstract][Full Text] [Related]
15. Intracerebroventricularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats.
Wright JW; Roberts KA; Cook VI; Murray CE; Sardinia MF; Harding JW
Brain Res; 1990 Apr; 514(1):5-10. PubMed ID: 2357530
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of angiotensin II antagonists containing sarcosine in position 7.
Moore GJ; Oudeman EM; Ko D; Nystrom DM
J Med Chem; 1979 Sep; 22(9):1147-9. PubMed ID: 490564
[TBL] [Abstract][Full Text] [Related]
17. Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazolecarboxylic acids.
Kubo K; Kohara Y; Imamiya E; Sugiura Y; Inada Y; Furukawa Y; Nishikawa K; Naka T
J Med Chem; 1993 Jul; 36(15):2182-95. PubMed ID: 8340921
[TBL] [Abstract][Full Text] [Related]
18. Long-lasting inhibition of angiotensin response in rats by depot administration of octanoyl-[Leu8]-angiotensin II.
Abdulkader RC; Silva HB; Marcondes M; Vasconcelos EA; Paiva AC
J Pharm Pharmacol; 1979 Jan; 31(1):20-2. PubMed ID: 32360
[TBL] [Abstract][Full Text] [Related]
19. Long-acting angiotensin II inhibitors containing hexafluorovaline in position 8.
Hsieh KH; Needleman P; Marshall GR
J Med Chem; 1987 Jun; 30(6):1097-100. PubMed ID: 3585907
[TBL] [Abstract][Full Text] [Related]
20. Hypotensive effects of angiotensin II analogues and angiotensin converting enzyme inhibitors in water-deprived Brattleboro rats.
Tomlinson KC; Gardiner SM; Bennett T
J Cardiovasc Pharmacol; 1990 Apr; 15(4):562-8. PubMed ID: 1691384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
